Annexin Pharmaceuticals AB (publ) (STO:ANNX)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.2880
+0.0080 (2.86%)
Apr 30, 2025, 12:59 PM CET

STO:ANNX Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-50.25-44.05-40.73-52.14-44.24
Upgrade
Depreciation & Amortization
0.190.190.190.190.19
Upgrade
Other Operating Activities
00-5.194.28
Upgrade
Change in Accounts Payable
-1.371-0.180.610.49
Upgrade
Change in Other Net Operating Assets
1.2-0.54-0.451.130.08
Upgrade
Operating Cash Flow
-50.23-43.4-41.17-45.02-39.2
Upgrade
Investment in Securities
-0.1-0.26--0.1
Upgrade
Investing Cash Flow
-0.1-0.26--0.1
Upgrade
Long-Term Debt Issued
510-204
Upgrade
Long-Term Debt Repaid
-----4.23
Upgrade
Net Debt Issued (Repaid)
510-20-0.23
Upgrade
Issuance of Common Stock
40.0626.523.1166.6661.01
Upgrade
Other Financing Activities
0.1-2.9-0.05-10.29-7.62
Upgrade
Financing Cash Flow
45.1533.6123.0676.3753.16
Upgrade
Miscellaneous Cash Flow Adjustments
-0-0---
Upgrade
Net Cash Flow
-5.08-9.7-18.3731.3513.87
Upgrade
Free Cash Flow
-50.23-43.4-41.17-45.02-39.2
Upgrade
Free Cash Flow Per Share
-0.11-0.26-0.28-0.55-0.64
Upgrade
Cash Interest Paid
0.050--0.5
Upgrade
Levered Free Cash Flow
-31.48-26.87-26.05-28.92-23.16
Upgrade
Unlevered Free Cash Flow
-31.48-26.87-26.05-27.76-22.85
Upgrade
Change in Net Working Capital
0.17-0.460.83-5.07-4.85
Upgrade
Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.